HarNeedi - Healthcare & Pharma Job Portal

Healthcare & Pharma Articles

Sustainable Growth of Indian Healthcare Industries

Indian Healthcare Industry: Sustainable Growth:

Indian healthcare industry is on a robust growth curve with enormous scope for investing in new specialty/multi specialty hospitals (or) expansion of existing facilities in recent days and installation of advanced equipments/technology up gradation. According to industry experts, definitely these factors will enable healthcare players to serve the increasing patient population to access qualitative diagnosis and treatment at affordable price models.

Industry Snapshot:

According to a report by an industry body, The Indian health care sector is reckoned to be the engine of the economy in the coming years.

Health care industry in India is predicted to reach US $150 billion by 2017 and approx. US $ 250 billion by 2020, contributing an expected Gross Domestic Product spend of 8 % by 2012 from 5.5 % in 2009. The segment from dedicated pharmacies to medical colleges, gives up bigger investment avenues and competitive advantages, modern facil

continue reading
1 readers |0 Comments|Reply

Few tips to minimize failures of Regulatory audits

Regulatory audits : Few tips to minimize failures:

Getting wrong in a regulatory audit can lead to many negative consequences. Before anything else it can maculate a company's reputation, cause to negative publicity; Secondly, it demands to more scrutiny hereafter audits of any regulatory body and ultimately, failing in a regulatory inspection can delay or can directly impact the market release of a medicine product or it can be delayed, which can considerably have a negative mark on reputation and financial outlook of the organization. Therefore, if the upshots of failed audits are so prejudicious, how life science players can better prepare to handle and manageregulatory audits to minimize the chances of a failed inspection.

Biopharma companies should consider their method of preparation for audit and carry out activities as a highly important project and give it the same importance as other key regulatory and abidance projects. The regulatory abidance procedures are progressively

continue reading
1 readers |0 Comments|Reply

Functions of state, central drug authorities of India

Under the Drug and Cosmetics Act, the regulation of manufacture, sale and distribution of Drugs is primarily the concern of the State authorities while the Central Authorities are responsible for approval of New Drugs, Clinical Trials in the country, laying down the standards for Drugs, control over the quality of imported Drugs, coordination of the activities of State Drug Control Organisations and providing expert advice with a view of bring about the uniformity in the enforcement of the Drugs and Cosmetics Act.

Drug Controller General of India is responsible for approval of licenses of specified categories of Drugs such as blood and blood products, I. V. Fluids, Vaccine and Sera.Central Drugs Standard Control Organization Head quarter is located at FDA Bhawan, Kotla Road, New Delhi 110002 and functions under the Directorate General of Health Services.

Continue Reading @ https://bit.ly/2F1a0TZ

For more updates visit HarNeedi.com 

continue reading
2 readers |0 Comments|Reply

Indian Pharmaceutical industries structure

Pharmaceuticals Industry Structure : India

The Indian Pharmaceuticals Industry has undergone a massive makeover from a regime of ?process patents in the seventies to a more modern and WTO compatible regime under the TRIPs agreement in 2005. It is among the top science based industries in India with wide ranging capabilities in field of drug manufacture and technology ensuring quality and diversification.

The Indian pharmaceutical industry is fragmented with more than 10,000 manufacturers in the organised and unorganised segments. Pharmaceutical manufacturing units are largely concentrated in states of Maharashtra, Gujarat,Andhra Pradesh, Telangana. These states account for about 45% of the total number of pharmaceutical manufacturing units in India.

Continue Reading @ https://bit.ly/2HavUVv

For more updates visit HarNeedi.com

continue reading
1 readers |0 Comments|Reply

Effective communication tips in Healthcare

Tips for Effective Communication in Healthcare

Communication is the process of sharing information, opinion and feeling between people through speaking, writing or body languages. Effective communication prolongs the concept that transmitted content is clearly and successfully delivered, received and understood by someone in the way it was intended.

In a healthcare setting, effective communication between patients and healthcare professional is very important to provide great patient care and improve patient satisfaction. It encompasses the ability of healthcare professional to collect information in order to facilitate accurate diagnosis, appropriately counseling, therapeutic instructions, and establish caring relationships with patients.

Many medical professionals tend to overestimate their ability in communication which leads to patient dissatisfaction and complaints. Ineffective communication can lead to improper diagnosis and delayed or improper medical treatment.

Continue Rea

continue reading
2 readers |0 Comments|Reply

Clear vision of India’s Sluggish Healthcare system

The new National Health Policy is promising, but it needs stronger Centre-State coordination:

The new National Health Policy (2017) released last week presents a clear vision of how India's sluggish health system can be galvanised to deliver health and well-being to all by 2030, to meet the Sustainable Development Goal on health. The real challenge lies in its operational amplification and effective implementation which call for cementing consensus, catalysing commitment and channelling close coordination for steering Centre and the States together to deliver on this vision.

After a gestation period of over two years, that saw extensive public comment and sharp debate within the government, the policy has finally emerged as a well-crafted document that lays the path for Universal Health Coverage (UHC). Though the right to health proposed in the earlier draft has been disappointingly deleted, effective implementation of the various measures proposed in the NHP should place us on the p

continue reading
3 readers |0 Comments|Reply

The discovery of the vitamin types

Vitamins : Types, discovery and what do they do for you..?

Vitamins are organic compounds required by living organisms in smaller amounts as a vital nutritive in order to perform the processes of life. Vitamins supplied from food, as the living things either doesn’t develop of them or none at all. An organic compound that contains carbon molecule when a living thing cannot develop sufficient amounts of an organic chemical compound and it has to derive from food is known as a “Vitamin”; are classified by their biological and chemical activity. Therefore, each “vitamin” relates to a number of “vitamer compounds “that all demonstrate the biological activity link up with a particular vitamin. Such a set of chemicals sorted under an alphabetised vitamin “generic signifier” title, such as “vitamin A”. By definition, vitamer compounds are transformable to the active form of the vitamin in the body, and are sometimes inter- transformable to one another, as well.

Vitamins carry out lot of act

continue reading
2 readers |0 Comments|Reply

Planning and designing of the Clinical Study

Clinical Study Design:


The principal objective is to develop a methodology where it will be possible to address all the anticipated issues as at the beginning of the trial and as well as all unidentified issues which generally lands during the conduct and analysis of the study. Adoption of a strong study design planning is a must do impression in order to make the trial execution more effective. It helps to bridge between risk factors and outcome. A well established study design can reduce the systematic errors (Bias). Central importance of Clinical Trials based on their study designs by which the advantages outweigh the disadvantages of the errors those are the most frequent and common for maximum trial type. Prevalent errors which may prove to be vulnerable towards the achievement of specified goal of the study can be avoid by a robust planning and designing of the Clinical Study.

Design Types:

Treatment Studies 

1. Randomized controlled trial 

* Double-blind rand

continue reading
2 readers |0 Comments|Reply

Policies and Interventions to Improve Antibiotics Use

Commitment,Accountability, Policies and Interventions to Improve Antibiotic Use:

Antibiotics have transformed the practice of medicine, making once lethal infections readily treatable and making other medical advances, like cancer chemotherapy and organ transplants, possible. The prompt initiation of antibiotics to treat infections has been proven to reduce morbidity and save lives, with a recent example being the rapid administration of antibiotics in the management of sepsis. However, 30-50% of all antibiotics prescribed in acute care hospitals are either unnecessary or inappropriate. 

Like all medications, antibiotics have serious side effects, including adverse drug reactions and Clostridium difficile infection (CDI). Patients who are unnecessarily exposed to antibiotics are placed at risk for serious adverse events with no clinical benefit. The misuse of antibiotics has also contributed to the growing problem of antibiotic resistance, which has become one of the most serious and

continue reading
1 readers |0 Comments|Reply

Trends in Indian Healthcare Industries

Trends in Indian Healthcare…

The healthcare sector in India is intended to grow at a compounded Annual Growth Rate (CAGR) of 15 % to touch $158.2 billion in 2017 from $78.6 billion in 2012. Also healthcare spending in India was figured 5 % of gross domestic product (GDP) in 2013 and is anticipated to remain at that level through 2016. Total health care spending in local-currency terms is protruded to rise at an annual rate of over 12 %, from an estimated $96.3 billion in 2013 to $195.7 billion in 2018. While this speedy growth rate will bring back high inflation, it will also be repelled by increasing public and private expenditures on health.

The healthcare industry has come a long way from the situations when patients who could afford it had to go overseas; nowadays patients from many countries are constellating to India for their medical emergencies. We know medical services in India delivered via public and private sector. However the government funds apportioned to healthcare se

continue reading
2 readers |0 Comments|Reply